Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kleinman

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Cell|March 17, 2023
Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegenerationSima Khazaei, Carol C L Chen, Augusto Faria Andrade, et al.
Cancer Discovery|March 20, 2021
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric GliomasMaria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Nature Cancer|June 23, 2022
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Cancer Discovery|April 4, 2024
The Virtual ChildRichard J Gilbertson, Sam Behjati, Anna-Lisa Böttcher, et al.
Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Cancer Research|July 8, 2022
FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional CircuitsJessica W Tsai, Paloma Cejas, Dayle K Wang, et al.
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Cell|March 17, 2023
Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegenerationSima Khazaei, Carol C L Chen, Augusto Faria Andrade, et al.
Cancer Discovery|March 20, 2021
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric GliomasMaria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Nature Cancer|June 23, 2022
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Cancer Discovery|April 4, 2024
The Virtual ChildRichard J Gilbertson, Sam Behjati, Anna-Lisa Böttcher, et al.
Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Cancer Research|July 8, 2022
FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional CircuitsJessica W Tsai, Paloma Cejas, Dayle K Wang, et al.
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Nature Communications|October 9, 2025
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Pageof 19